Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 101 to 150 of 6456 in total
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
51\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fip1-like 1; rearranged in hypereosinophilia. [source:refseq;acc:nm\_030917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23640.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19479.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4160.4\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
52\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase dna binding protein 5. [source:refseq;acc:nm\_015557]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 73 kda subunit (cpsf 73 kda subunit). [source:swissprot;acc:q9ukf6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23422.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19380.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4042.1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
53\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase alpha (ec 2.7.7.19) (pap) (polynucleotide adenylyltransferase alpha) (fragment). [source:swissprot;acc:p51003]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23326.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19296.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4030.1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
54\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex 2. [source:refseq;acc:nm\_020892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1618.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2651.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63814\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec5. [source:swissprot;acc:q96kp1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23316\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19288.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4027.2\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
55\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex homolog 1; hdx-1. [source:refseq;acc:nm\_004416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1629.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2662.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63399\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
23303.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19279.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4023.6\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
56\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding a; ras-related gtp-binding protein. [source:refseq;acc:nm\_006570]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
20911\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24908.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3997.5\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-lak cell-originated protein kinase; spermatogenesis-related protein kinase; pdz-binding kinase; pbk; mapkk-like protein kinase; serine/threonine protein kinase. [source:refseq;acc:nm\_018492]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
57\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 3; sam68-like phosphotyrosine protein, t-star. [source:refseq;acc:nm\_006558]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding c; rag c protein. [source:refseq;acc:nm\_022157]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20911\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24908.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3997.5\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
58\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 1; gap-associated tyrosine phosphoprotein p62 (sam68). [source:refseq;acc:nm\_006559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding b short isoform; gtp-binding protein ragb. [source:refseq;acc:nm\_006064]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
20911\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
24908.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3997.5\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
59\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
anillin, actin binding protein (scraps homolog, drosophila); anillin (drosophila scraps homolog), actin binding protein. [source:refseq;acc:nm\_018685]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain-containing, rna-binding, signal transduction-associated protein 2; sam68-like mammalian protein 1. [source:refseq;acc:nm\_152688]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
60\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
16771.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12889.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3882.4\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
61\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3832\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, brain form (ec 2.4.1.1). [source:swissprot;acc:p11216]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
62\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3832\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, liver form (ec 2.4.1.1). [source:swissprot;acc:p06737]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3832\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22515.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18702.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3812.9\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1657.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2690.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6229\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17757.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14008\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3749.5\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17756.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14007.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3749.2\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3742.9\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.6\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
70\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3742.8\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
71\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54716\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, alpha isoform (pp2a, b subunit, b' alpha isoform) (pp2a, b subunit, b56 alpha isoform) (pp2a, b subunit, pr61 alpha isoform) (pp2a, b subunit, r5 alpha isoform). [source:swissprot;acc:q15172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3742.8\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
72\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17710.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13977.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3733.2\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54715\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
73\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4556.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54711\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase pp1-gamma catalytic subunit (ec 3.1.3.16) (pp-1g). [source:swissprot;acc:p36873]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
22268.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18560.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3708.4\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
74\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54694\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
75\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1920.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2907.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.5137\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/